Peptides DB
Research-centric peptide and protocol reference hub
Study 63 of 65HCG (Human Chorionic Gonadotropin) literatureCase reports in women's health · Case report2026

Successful fertility-preserving management of a viable cesarean scar ectopic pregnancy: a case report.

This case illustrates that a multidisciplinary approach to managing viable cesarean scar ectopic pregnancy can effectively reduce hemorrhagic risk while preserving fertility.

Read at Case reports in women's healthAdd to compare

Where it sits

this study against the rest of the hcg (human chorionic gonadotropin) corpus
9
Preclinical
51
Observational · this one
0
Open-label
3
Randomised
2
Reviews

Summary and findings

This case report discusses the management of a viable cesarean scar ectopic pregnancy in a 27-year-old woman who had persistent fetal cardiac activity despite treatment with methotrexate. A multidisciplinary approach involving prophylactic bilateral uterine artery embolization and laparoscopic suction curettage was utilized. The patient had an estimated blood loss of 20 mL and normalized β-hCG levels at follow-up.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Estimated blood loss of 20 mL.n=12026

Abstract

The authors’ words, as Case reports in women's health supplied them

Cesarean scar ectopic pregnancy (CSEP) is an increasingly recognized complication of prior cesarean delivery, associated with uterine rupture, hemorrhage, and hysterectomy. This report presents a case of viable cesarean scar ectopic pregnancy with persistent fetal cardiac activity despite systemic methotrexate, successfully managed with a multidisciplinary, fertility-preserving approach. A 27-year-old woman (G7P5) with two prior cesarean deliveries presented at 5 weeks of gestation with vaginal spotting and pelvic pain. Initial transvaginal ultrasound showed a viable intrauterine pregnancy. She developed heavy bleeding, and repeat ultrasound revealed a gestational sac implanted in the anterior lower uterine segment at the prior cesarean scar with persistent fetal cardiac activity. A one-week, four-dose course of intramuscular methotrexate was initiated; however, gestational tissue showed minimal change and β-hCG levels remained elevated. Given her desire for future fertility and the hemorrhagic risk of surgical evacuation alone, a multidisciplinary approach involving maternal-fetal medicine, interventional radiology, and gynecologic surgery was pursued. Prophylactic bilateral uterine artery embolization followed by laparoscopy and ultrasound-guided suction curettage was successfully performed with an estimated blood loss of 20 mL. At follow-up, the patient remained clinically well with normalized β-hCG levels. As cesarean delivery rates rise, cesarean scar ectopic pregnancy and its complications are expected to increase. Management should be individualized based on fetal viability, myometrial invasion, and reproductive goals. While conservative treatment may be appropriate in select cases, viable cesarean scar ectopic pregnancy with persistent cardiac activity requires multimodal management. This case demonstrates that prophylactic uterine artery embolization followed by minimally invasive evacuation can reduce hemorrhagic risk while preserving fertility.

Background

Cesarean scar ectopic pregnancy (CSEP) is a complication that can arise following cesarean deliveries, with risks including uterine rupture and hemorrhage. Previous management strategies often involve surgical intervention, but this report highlights a fertility-preserving approach. Understanding effective management options for CSEP is critical as cesarean delivery rates continue to rise.

Methods

This case report details the management of a single patient, a 27-year-old woman (G7P5) presenting at 5 weeks of gestation. Initial treatment involved a one-week, four-dose course of intramuscular methotrexate, followed by a multidisciplinary intervention including bilateral uterine artery embolization and laparoscopic suction curettage. The primary outcome was the reduction of hemorrhagic risk while preserving fertility.

Results

The estimated blood loss during the procedure was 20 mL. Following the intervention, the patient had normalized β-hCG levels at follow-up.

Interpretation

This case adds to the limited literature on managing viable CSEP, suggesting that a multidisciplinary approach can be effective in preserving fertility while minimizing complications. The small estimated blood loss indicates a potentially favorable outcome, but the clinical significance of this case is limited by its single-patient design. Further studies are needed to validate these findings across larger populations.

Key findings

  • Estimated blood loss of 20 mL during the procedure.
  • Patient remained clinically well at follow-up with normalized β-hCG levels.

Limitations

  • Single case report with n=1.
  • No control group for comparison.
  • Not reported in abstract.

Elsewhere in the HCG (Human Chorionic Gonadotropin) corpus

BEarly pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma.Seminars in oncology · 2026 · n=1 · Not reported in abstract.HumanBEndometrial ultrasound features associated with methotrexate success in tubal ectopic pregnancy: a prospective case series.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2024 · n=177 · Treatment success occurred in 94 of 177 women (53.1%).HumanBEndometrial ultrasound features associated with methotrexate success in tubal ectopic pregnancy: a prospective case series.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2026 · 53.1% treatment success in 177 women.HumanCSR-18292 Alters Oocyte Competence and Ovarian Transcriptomic Dynamics in Female Micebiorxiv-preprint · 2026 · Not reported in abstract.AnimalBHigh-grade endometrioid carcinoma arising from uterine serosal endometriosis with focal choriocarcinomatous differentiation and embryonal carcinoma-like morphology: a case report and literature reviewbiorxiv-preprint · 2023 · n=1 · Serum β-hCG remained persistently below 1 mIU/mL throughout follow-up.HumanBEfficacy of hysteroscopic curettage and niche resection in type II and III cesarean scar pregnancies.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026 · n=105 · 20 (15,25) min vs 25 (20,31) min operation time, p=0.001Human